Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6859)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2013 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jun CH, Ki HS, Lee HK, Park KJ, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK, Rew JS. Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma. World J Gastroenterol 2013; 19(2): 284-289 [PMID: 23345952 DOI: 10.3748/wjg.v19.i2.284] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i2/284.htm |
| Number | Citing Articles |
| 1 |
Andrei Florin Bloj, Ioana Hălmaciu, Bogdan Andrei Suciu, Lucian Mărginean. Treatment of Hepatocellular Carcinomas by Hepatic Transarterial Chemoembolization, Case Presentation and Review of the Literature. Acta Medica Transilvanica 2020; 25(3): 32 doi: 10.2478/amtsb-2020-0046
|
| 2 |
Lukas Müller, Fabian Stoehr, Aline Mähringer-Kunz, Felix Hahn, Arndt Weinmann, Roman Kloeckner. Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step Guide. Journal of Hepatocellular Carcinoma 2021; : 403 doi: 10.2147/JHC.S285735
|
| 3 |
Yunan Wang, Zhihui Chang, Jiahe Zheng, Zhaoyu Liu, Jun Zhang. The impact of liver abscess formation on prognosis of patients with malignant liver tumors after transarterial chemoembolization. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1256012
|
| 4 |
Sith Siramolpiwat, Thanachai Punjachaipornpon, Bubpha Pornthisarn, Ratha-korn Vilaichone, Soonthorn Chonprasertsuk, Anupong Tangaroonsanti, Patommatat Bhanthumkomol, Achara Phumyen, Atipat Yasiri, Mayurachat Kaewmanee. N-Acetylcysteine Prevents Post-embolization Syndrome in Patients with Hepatocellular Carcinoma Following Transarterial Chemoembolization. Digestive Diseases and Sciences 2019; 64(11): 3337 doi: 10.1007/s10620-019-05652-0
|
| 5 |
Helen Blackburn, Sandra West. Management of Postembolization Syndrome Following Hepatic Transarterial Chemoembolization for Primary or Metastatic Liver Cancer. Cancer Nursing 2016; 39(5): E1 doi: 10.1097/NCC.0000000000000302
|
| 6 |
N. Mandolfo, A. Berger, M. Hammer. Glycemic variability in patients with gastrointestinal cancer: An integrative review. European Journal of Oncology Nursing 2020; 48: 101797 doi: 10.1016/j.ejon.2020.101797
|
| 7 |
HIROKI NISHIKAWA, YUKIO OSAKI, RYUICHI KITA, TORU KIMURA, YOSHIAKI OHARA, HARUHIKO TAKEDA, AZUSA SAKAMOTO, SUMIO SAITO, NORIHIRO NISHIJIMA, AKIHIRO NASU, HIDEYUKI KOMEKADO, SHUHEI NISHIGUCHI. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma. Oncology Reports 2014; 31(1): 65 doi: 10.3892/or.2013.2845
|
| 8 |
Rohan Chaminda Siriwardana, Madunil Anuk Niriella, Anuradha Supun Dassanayake, Chandika Anuradha Habarakada Liyanage, Angappulige Upasena, Chandra Sirigampala, Hithanadura Janaka de Silva. Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0329-8
|
| 9 |
Yi Pan, Rui Chang, Zhonglin He, Ming Hong. How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?. Medicine 2021; 100(14): e25360 doi: 10.1097/MD.0000000000025360
|
| 10 |
Meredith C. Mason, Nader N. Massarweh, Aitua Salami, Mark A. Sultenfuss, Daniel A. Anaya. Post‐embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma. HPB 2015; 17(12): 1137 doi: 10.1111/hpb.12487
|
| 11 |
Seung Ji Kang, Uh Jin Kim, Seong Eun Kim, Joon Hwan An, Mi Ok Jang, Dae-Seong Myung, Kyung-Hwa Park, Sook-In Jung, Sung Bum Cho, Hee-Chang Jang, Young Eun Joo. Predictive Value of Procalcitonin for Bacterial Infection after Transarterial Chemoembolization or Radiofrequency Ablation for Hepatocellular Carcinoma. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/9120878
|
| 12 |
Jinpeng Li, Congcong Shi, Jutian Shi, Jinlong Song, Nan Wang. Determination of risk factors for fever after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. Medicine 2021; 100(44): e27636 doi: 10.1097/MD.0000000000027636
|
| 13 |
Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Phurich Janjindamai, Surasit Akkakrisee, Teerha Piratvisuth, Alan Geater. Decision-Making Scoring System for the Repetition of Conventional Transarterial Chemoembolization in Patients With Inoperable Hepatocellular Carcinoma. Clinical and Translational Gastroenterology 2022; 13(7): e00506 doi: 10.14309/ctg.0000000000000506
|
| 14 |
Muhammet Arslan, Serkan Degirmencioglu. Risk Factors for Postembolization Syndrome After Transcatheter Arterial Chemoembolization. Current Medical Imaging Formerly Current Medical Imaging Reviews 2019; 15(4): 380 doi: 10.2174/1573405615666181122145330
|
| 15 |
Chandan K. Kedarisetty, Sipra Bal, Subhashree Parida, Mayank Jain, Ajeet S. Bhadoria, Joy Varghese, Jayanthi Venkataraman. Role of N-acetyl Cysteine in Post-transarterial Chemoembolization Transaminitis in Hepatocellular Carcinoma: A Single-center Experience. Journal of Clinical and Experimental Hepatology 2021; 11(3): 299 doi: 10.1016/j.jceh.2020.10.007
|
| 16 |
Chien‐Wei Peng, Wei Teng, Yi‐Chung Hsieh, Wen‐Juei Jeng, Chien‐Hao Huang, Kar‐Wai Lui, Chen‐Fu Hung, Yi‐Cheng Chen, Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin, I‐Shyan Sheen. Postembolization fever after transarterial chemoembolization is a sign of unfavorable therapeutic response in hepatocellular carcinoma patients. Advances in Digestive Medicine 2020; 7(2): 83 doi: 10.1002/aid2.13182
|
| 17 |
Anan Abu Rmilah, Mohammad N. Qrareya, Chad Fleming, Adham K. Alkurashi, Scott Nyberg, Michael Leise, James C. Andrews. Association of Cirrhosis and Other Patient and Procedural Characteristics With Postembolization Syndrome After Bland Hepatic Artery Embolization for Hepatic Malignancy. American Journal of Roentgenology 2022; 218(6): 1030 doi: 10.2214/AJR.21.26806
|
| 18 |
Adam Hatzidakis, Lukas Müller, Miltiadis Krokidis, Roman Kloeckner. Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations. Cancers 2022; 14(10): 2469 doi: 10.3390/cancers14102469
|
| 19 |
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies. Cancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914
|
| 20 |
Jing-Jing He, Xi-Xi Yin, Ting Wang, Min-Ying Chen, Xi-Long Li, Xin-Jing Yang, Hong-Yan Shao. Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization. Journal of Cancer Research and Therapeutics 2021; 17(3): 777 doi: 10.4103/jcrt.jcrt_132_21
|